Optimizing Care for Patients with Relapsed/Refractory Multiple Myeloma

Title:

Optimizing Care for Patients with Relapsed/Refractory Multiple Myeloma

Topic: Oncology/ Hematology
Relevant Terms: Cancer, Multiple Myeloma
Primary Audience: Hematologists; Oncologists; Oncology Pharmacists
Launch Date: 09-Nov-12
Credits: AMA PRA Category 1 Credit
1 ACPE contact hour
Expiration Date: The accreditation for this activity has expired.
Patients Seen:  Mr Johnson Mrs Anderson
Curriculum Name: Optimizing Care for Patients with Relapsed/Refractory Multiple Myeloma

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Assess outcomes for patients with relapsed/refractory multiple myeloma
  2. Evaluate the biological role of therapies in development for multiple myeloma
  3. Compare and contrast efficacy and safety data for novel agents in the treatment of relapsed/refractory multiple myeloma
  4. Formulate an appropriate, individualized treatment approach when given relapsed/refractory multiple myeloma case scenarios designed to achieve optimal patient outcomes
  5. Evaluate patients with relapsed/refractory multiple myeloma suitable for enrollment in ongoing clinical trials

    Faculty

    Martha Q. Lacy, MD
    Professor of Medicine
    Division of Hematology
    Mayo Clinic College of Medicine
    Rochester, Minnesota
    Elizabeth Bilotti, MSN, RN, APN
    John Theurer Cancer Center
    Hackensack University Medical Center
    Hackensack, New Jersey
    Katherine Sanvidge Shah, PharmD, BCOP
    Hematology/Oncology Pharmacy Specialist
    Emory University Hospital
    Winship Cancer Institute
    Atlanta, Georgia
    Thomas G. Martin III, MD
    Clinical Professor of Medicine
    Multiple Myeloma Translational Initiative
    UCSF Medical Center
    University of California, San Francisco
    San Francisco, California
    Estimated time to complete activity: 1 hour
    Release date: Friday, November 9, 2012 | Expiration date: Friday, November 8, 2013
     
    TARGET AUDIENCE
    The target audience for this activity is medical oncologists, hematologist-oncologists, oncology pharmacists, and oncology nurses caring for patients with relapsed/refractory multiple myeloma.
     
    DESIGNATION OF CREDIT
    PHYSICIAN CONTINUING EDUCATION
    Accreditation Statement

    Educational Concepts Group, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    Credit Designation Statement
    Educational Concepts Group, LLC designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
     
    PHARMACIST CONTINUING EDUCATION
    Educational Concepts Group, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    Educational Concepts Group, LLC designates this continuing education activity for 1.0 contact hour (0.10 CEU) (UAN
    0199-0000-12-038-H01-P).
     
    Type of activity: Application-based
     
    METHOD OF PARTICIPATION
    There are no fees for participating and receiving CME/CE credit for this activity. During the period Friday, November 9, 2012 through Friday, November 8, 2013, participants must 1) read the educational objectives and faculty disclosures; 2) study the educational activity; 3) complete the post-activity assessment.
     
    CME/CE CREDIT
    Physicians and pharmacists who complete the post-activity assessment with a score of 70% or better may view and print their credit letter or statement of credit via the website, www.educationalconcepts.net.
     
    POLICY ON DISCLOSURE
    It is the policy of ECG that the faculty, authors, planners, and other persons who may influence content of this CME/CE activity disclose all relevant financial relationships with commercial interests in order to allow ECG to identify and resolve any potential conflicts of interest.
     
    The Following Faculty Members Have Declared Relevant Financial Relationships
     

    Elizabeth Bilotti, MSN, RN, APN
     
    Grants/Research Support, Consultant Fees, Honorarium
    Celgene Corporation, Millennium: The Takeda Oncology Company
     
    Martha Q. Lacy, MD
     
    Grants/Research Support
    Celgene Corporation

    Thomas G. Martin III, MD
     
    Grants/Research Support
    Celgene Corporation
     
    Consultant Fees
    Novartis
     
    Speakers' Bureau
    Celgene Corporation, Novartis

    Katherine Sanvidge Shah, PharmD, BCOP
     
    Honorarium
    Millennium: The Takeda Oncology Company
     
    Staff Disclosure
    Planners and managers at ECG have no relevant financial relationships to disclose.
     
    DISCLOSURE OF OFF-LABEL USE
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. ECG does not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity do not necessarily represent the views of ECG. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    DISCLAIMER
    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

    Please refer to the official prescribing information for each product or consult the Physicians' Desk Reference for discussion of approved indications, contraindications, and warnings.

    ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT
    This activity is supported by an educational grant from
    Onyx Pharmaceuticals, Inc.

    CME/CE INQUIRIES
    For further information, please contact:
    Educational Concepts Group, LLC
    1300 Parkwood Circle SE, Suite 325
    Atlanta, Georgia 30339
    Phone: 1.866.933.1681
    Fax: 1.866.933.1692
    www.educationalconcepts.net

    This activity is sponsored by Educational Concepts Group, LLC

     

    This activity is supported by an educational grant from
    Onyx Pharmaceuticals, Inc.